Jinhe Biotechnology Co. Ltd. | Ownership
Companies that own Jinhe Biotechnology Co. Ltd.
Bosera Asset Management Co., Ltd.
24,010,125
4.54%
0
0.14%
03/31/2017
Guosen Securities Co., Ltd. (Investment Management)
10,058,400
1.9%
1,000
0.36%
03/31/2017
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)
4,684,715
0.89%
4,684,715
0.09%
03/31/2017
Zheshang Fund Management Co., Ltd.
1,988,593
0.38%
1,988,593
0.8%
03/31/2017
UBS SDIC Fund Management Co., Ltd.
477,556
0.09%
-3,115,803
0.03%
12/31/2017
GF Fund Management Co., Ltd.
192,800
0.04%
-981,300
0%
12/31/2017
CICC Fund Management Ltd.
9,100
0%
9,100
0.01%
12/31/2017
Lion Fund Management Co., Ltd.
0
0%
-85,389
0%
12/31/2017
Truvalue Asset Management Co. Ltd.
0
0%
-504,300
0%
12/31/2017
Penghua Fund Management Co., Ltd.
0
0%
-2,999,997
0%
12/31/2017
| Address |
No. 71 Xinping Road
Hohhot Inner Mongolia 010200
China
|
|
Employees
|
- |
| Website |
http://www.jinhe.com.cn |
| Updated |
07/08/2019 |
| Jinhe Biotechnology Co., Ltd. engages in the manufacture and sale of veterinary medicines. Its products include chlortetracycline feed grade, chlortetracycline hydrochloride, and salinomycin. The company was founded on March 14, 1990 and is headquartered in Hohhot, China. |
